[HTML][HTML] Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA. 1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
The Omicron variant is rapidly becoming the dominant SARS-CoV-2 virus circulating globally.
It is important to define reductions in virus neutralizing activity in the serum of convalescent …
It is important to define reductions in virus neutralizing activity in the serum of convalescent …
[HTML][HTML] Kinetics of viral load and antibody response in relation to COVID-19 severity
…, Z Chen, Z Zhuang, J Zhuo, C Chen… - The Journal of …, 2020 - Am Soc Clin Investig
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution…
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution…
[PDF][PDF] Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment
…, R Chen, AN Alshukairi, Z Chen, Z Zhang, C Chen… - Cell, 2020 - cell.com
COVID-19, caused by SARS-CoV-2, is a virulent pneumonia, with >4,000,000 confirmed
cases worldwide and >290,000 deaths as of May 15, 2020. It is critical that vaccines and …
cases worldwide and >290,000 deaths as of May 15, 2020. It is critical that vaccines and …
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong
CKP Mok, CA Cohen, SMS Cheng, C Chen… - …, 2022 - Wiley Online Library
Background and objective Few head‐to‐head evaluations of immune responses to different
vaccines have been reported. Methods Surrogate virus neutralization test (sVNT) antibody …
vaccines have been reported. Methods Surrogate virus neutralization test (sVNT) antibody …
[HTML][HTML] Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
…, JYL Ching, Y Liu, S Yan, DLS Chan, J Zhu, C Chen… - Gut, 2022 - gut.bmj.com
Objective The gut microbiota plays a key role in modulating host immune response. We
conducted a prospective, observational study to examine gut microbiota composition in …
conducted a prospective, observational study to examine gut microbiota composition in …
[HTML][HTML] Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery
…, F Li, Z Zhuang, Z Chen, L Luo, D Liu, C Chen… - Signal transduction and …, 2021 - nature.com
Disease progression prediction and therapeutic drug target discovery for Coronavirus disease
2019 (COVID-19) are particularly important, as there is still no effective strategy for severe …
2019 (COVID-19) are particularly important, as there is still no effective strategy for severe …
[HTML][HTML] SARS-CoV-2 Omicron variant BA. 2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong …
Background Omicron subvariant BA.2 circulation is rapidly increasing globally. Aim We
evaluated the neutralising antibody response from vaccination or prior SARS-CoV-2 infection …
evaluated the neutralising antibody response from vaccination or prior SARS-CoV-2 infection …
A randomized clinical trial using CoronaVac or BNT162b2 vaccine as a third dose in adults vaccinated with two doses of CoronaVac
CKP Mok, C Chen, K Yiu, TO Chan, KC Lai… - American journal of …, 2022 - atsjournals.org
Methods Of the 360 participants who had received two doses of CoronaVac as part of our
previous study (3), 260 showed surrogate neutralization test (sVNT) results below 60% in their …
previous study (3), 260 showed surrogate neutralization test (sVNT) results below 60% in their …
[HTML][HTML] Plaque-neutralizing antibody to BA. 2.12. 1, BA. 4 and BA. 5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and …
Background BA.2.12.1, BA.4 and BA.5 subvariants of SARS-CoV-2 variant-of-concern (VOC)
Omicron (B.1.1.529) are spreading globally. They demonstrate higher transmissibility and …
Omicron (B.1.1.529) are spreading globally. They demonstrate higher transmissibility and …
[HTML][HTML] Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or …
Omicron, a novel SARS-CoV-2 variant has emerged and is rapidly becoming the dominant
SARS-CoV-2 virus circulating globally. It is important to define reductions in virus neutralizing …
SARS-CoV-2 virus circulating globally. It is important to define reductions in virus neutralizing …